Senior health care professionals in oncology will benefit from attending the Cleveland Clinic's 2009 Medical Innovation Summit, October 5-7 in Cleveland. The Summit has a reputation of unveiling new medical technologies and the financial drivers behind them. More than 900 executives, investors, entrepreneurs and clinicians are expected to attend.

The theme this year is Improving the Prognosis: Cancer Cures Through Innovation. The Summit will showcase several live surgeries from the Taussig Cancer Institute and the Glickman Urological Institute. Participants will have the opportunity to speak with the Clinic's top physicians about particle therapies in radiation oncology, thoracic oncology and more.

An international, elite group of senior executives across the health care industry will be featured speakers, including Harry Rein, General Partner, Foundation Medical Partners, who will be focusing on investing in medical devices. The speakers will discuss a range of topics from radiotherapy technology, to new technology in health care, to the market for consumer genotyping in oncogenomics.

Summit highlights include networking opportunities for investors and executives, forums for leaders to discuss health care technology, insight into innovations in cancer therapies and disease management, analysis of support for research, and a summary of the top 10 medical innovations for 2010.

To register or learn more, visit www.clevelandclinic.org/innovations/summit/